Fuji Pharma Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, Fuji Pharma stock has a consensus rating of "Buy" and an average price target of ¥2,850. The average 1-year stock price forecast is 46.98% higher than the current stock price, while the lowest is ¥2,300 (+18.62%) and the highest is ¥3,400 (+75.35%).

Price Target: ¥2,850 (+46.98%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥2,300	¥2,850	¥2,850	¥3,400
Change	+18.62%	+46.98%	+46.98%	+75.35%

Analyst Ratings

The average analyst rating for Fuji Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Aug '25	Sep '25	Nov '25	Feb '26	May '26	Jun '26
Strong Buy	2	2	2	2	2	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Financial Forecast

Revenue This Year

59.59B

from 51.68B

15.32%

from 51.68B

Revenue Next Year

65.25B

from 59.59B

9.49%

from 59.59B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Sep 30, 2021	Sep 30, 2022	Sep 30, 2023	Sep 30, 2024	Sep 30, 2025	Sep 30, 2026
Revenue	33.99B	35.43B	40.89B	46.14B	51.68B	59.59B
Revenue Growth	0.58%	4.23%	15.42%	12.84%	12.01%	15.32%
Gross Profit	14.75B	14.56B	16.52B	17.84B	20.76B	24.76B
Gross Margin	43.40%	41.10%	40.39%	38.68%	40.18%	41.55%
Operating Income	3.35B	3.78B	3.86B	3.88B	4.99B	6.71B
Net Income	2.43B	2.70B	3.44B	6.15B	3.00B	1.98B
Dividend / Share	29.00	35.00	37.00	42.50	45.50	49.00
Dividend Growth	-	20.69%	5.71%	14.86%	7.06%	7.69%
Free Cash Flow	1.39B	-11.72B	-4.26B	599.13M	535.50M	-2.30B
No. Analysts	-	-	-	-	-	2

Financial currency is JPY.

Revenue Forecast

Revenue	2026	2027	2028
High	61.5B
Avg	59.6B
Low	57.7B

Revenue Growth

Revenue Growth	2026	2027	2028
High	19.0%
Avg	15.3%
Low	11.6%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-